Prognostic utility of macrophage polarization (CD68/CD163 ratio) in Egyptian JAK2 positive myeloproliferative neoplasm patients: a single center study. [PDF]
Diagn PatholMahgoub SMA, Yehia MSM, Arafat AMA.
europepmc +1 more source
Molecular genetic evaluation of myeloproliferative neoplasms [PDF]
, 2015 Elizabeth M. Azzato, Adam Bagg
openalex +1 more source
JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review
Dermatologic Therapy, Volume 2026, Issue 1, 2026.Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova +9 more
wiley +1 more source
Relapse of Acute Myelogenous Leukemia With History of Myeloproliferative Neoplasm and Exacerbation of Pulmonary Hypertension. [PDF]
JACC Case RepKaous M +7 more
europepmc +1 more source
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia [PDF]
, 2014 Bing Li, Robert Peter Gale, Zhijian Xiao
core +1 more source
Mediators of Inflammation, Volume 2026, Issue 1, 2026.Background The immune system and inflammatory proteins influence hematologic malignancies, but causal links with immune cell phenotypes are unclear. Methods We applied a prespecified, multistage workflow: two‐sample and multivariable Mendelian randomization (MVMR; 731 immune traits across 12 hematologic cancers), two‐step mediation Mendelian ...
Yi Jin +9 more
wiley +1 more source
The Causal Role of the Gut Microbiota-Plasma Metabolome Axis in Myeloproliferative Neoplasm Pathogenesis: A Mendelian Randomization and Mediation Analysis. [PDF]
MetabolitesKan H, Zhang K, Mao A, Geng L.
europepmc +1 more source
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era [PDF]
Anand Patel +24 more
openalex +1 more source
CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.ABSTRACT Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using data collected by central cancer registries (incidence, through 2022) and the National Center for Health Statistics (mortality, through 2023).
Rebecca L. Siegel +4 more
wiley +1 more source